Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma

Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic merkel cell carcinoma

10.1200/JCO.2009.21.8149

Saved in:

Bibliographic Details
Main Authors:	Davids, M., Charlton, A., Ng, S.-S., Chong, M.-L., Soong, R., Laubscher, K., Dar, M., Hodge, J., Goh, B.C.
Other Authors:	PHARMACOLOGY
Format:	Article
Published:	2011
Online Access:	http://scholarbank.nus.edu.sg/handle/10635/27284
Tags:	Add Tag No Tags, Be the first to tag this record!
Institution:	National University of Singapore

Similar Items

Multi-Targeted Tyrosine Kinase Inhibitor-Induced Hyperammonemic Encephalopathy: a Report of Two Cases Using Pazopanib, Sunitinib, and Regorafenib
by: Noppadon Kongsuphon, et al.
Published: (2020)

Virtual screening of selective multitarget kinase inhibitors by combinatorial support vector machines
by: Ma, X.H., et al.
Published: (2014)

A phase II study of pazopanib in asian patients with recurrent/metastatic nasopharyngeal carcinoma
by: Lim, W.-T., et al.
Published: (2016)

Unusual merkel cell carcinoma of the eyelid
by: Shah, J.M., et al.
Published: (2016)

Kill502, a novel multitargeted receptor tyrosine kinase inhibitor, induces growth arrest and apoptosis of human leukemia cells in vitro and in vivo
by: Nishioka, C, et al.
Published: (2020)

A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H
by: Bible, K.C., et al.
Published: (2016)

Induction chemotherapy followed by radiotherapy in Merkel-cell carcinoma
by: Poon D., et al.
Published: (2020)

Inhibitors of the tyrosine kinase signaling cascade for asthma
by: Wong, W.S.F.
Published: (2012)

Tyrosine kinase inhibitors: A new approach for asthma
by: Wong, W.S.F., et al.
Published: (2012)

Butein, a specific protein tyrosine kinase inhibitor
by: Yang, E.-B., et al.
Published: (2013)

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma
by: Lee, S.-C., et al.
Published: (2012)

Computational approach in searching for dual action multitarget inhibitors for osteosarcoma
by: Maria Apriliani Gani, -, et al.
Published: (2023)

Novel inhibitor for fibroblast growth factor receptor tyrosine kinase
by: Naparat Kammasud, et al.
Published: (2018)

Design and synthesis of receptor tyrosine kinase inhibitors for anticancer treatment
by: Chawannuch Mudjupa
Published: (2023)

Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: Results of a phase 2 consortium study
by: Bible, K.C., et al.
Published: (2016)

Merkel cell carcinoma and follicular lymphoma: A highly unusual collision tumor
by: Suknuntha K.
Published: (2023)

ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
by: Jasinghe, V.J., et al.
Published: (2011)

EFEKTIVITAS TYROSIN KINASE INHIBITOR PADA PENGHAMBATAN TOLERANSI ANTI NYERI OPIOID
by: Junaidi Khotib, S.Si., M.Kes., Ph.D., Apt., et al.
Published: (2008)

A spleen tyrosine kinase inhibitor reduces the severity of established glomerulonephritis
by: Jennifer Smith, et al.
Published: (2018)

Rapid synthesis of Abelson tyrosine kinase inhibitors using click chemistry
by: Kalesh, K.A., et al.
Published: (2014)

Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study
by: Erman Mustafa, et al.
Published: (2022)

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells
by: Boonyakorn Boonsri, et al.
Published: (2022)

EXPLORING THE ROLE OF PHARMACOKINETIC ALTERATIONS IN TYROSINE KINASE INHIBITORS (TKIS)-ASSOCIATED TOXICITIES
by: TEO YI LING
Published: (2015)

SRSF1-MEDIATED TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKAEMIA
by: SINNAKANNU JOANNA RAJESWARY
Published: (2018)

Efektivitas Tyrosin Kinase Inhibitor Pada Penghambatan Toleransi Anti Nyeri Opioid
by: Junaidi Khotib, -
Published: (2005)

ROLE OF INHIBITORS OF TYROSINE KINASE SIGNALING CASCADE IN AIRWAY SMOOTH MUSCLE FUNCTIONS
by: TSANG FAI
Published: (2019)

Lack of somatic mutations in VEGFR-2 tyrosine kinase domain in hepatocellular carcinoma
by: Chuah, B.Y.S., et al.
Published: (2014)

Phototoxic reaction induced by pazopanib
by: Siriorn Udompanich, et al.
Published: (2019)

Characteristics of Merkel Cell Polyomavirus T antigen oncoproteins.
by: Yu, Esther Dawen.
Published: (2009)

Anti-inflammatory effects of inhibitors of the tyrosine kinase signaling cascade in animal models of asthma
by: DUAN WEI
Published: (2010)

MECHANISMS OF HYPOXIA-INDUCED GROWTH AND TYROSINE KINASE INHIBITOR RESISTANCE IN CHRONIC MYELOID LEUKEMIA
by: MANJERI ADITI SUBRAMANIAM
Published: (2019)

Identification of vinyl sulfone derivatives as egfr tyrosine kinase inhibitor: In vitro and in silico studies
by: Thitinan Aiebchun, et al.
Published: (2022)

Risk of tyrosine kinase inhibitors-induced hepatotoxicity in cancer patients: A meta-analysis
by: Teo, Y.L., et al.
Published: (2014)

Tannic acid, a potent inhibitor of epidermal growth factor receptor tyrosine kinase
by: Yang, E.B., et al.
Published: (2014)

BIM mediates EGFR tyrosine kinase inhibitor-induced apoptosis in lung cancers with oncogenic EGFR mutations
by: Costa D.B., et al.
Published: (2018)

Knockout of glucosidase II beta subunit inhibits growth and metastatic potential of lung cancer cells by inhibiting receptor tyrosine kinase activities
by: Worapong Khaodee, et al.
Published: (2019)

BCR-ABL kinase domain mutations in tyrosine kinase inhibitors-naïve and -exposed Southeast Asian chronic myeloid leukemia patients
by: Wanwisa Wongboonma, et al.
Published: (2018)

Inhibitors of tyrosine kinase signaling cascade attenuated antigen challenge of guinea-pig airways in vitro
by: Wong, W.S.F., et al.
Published: (2012)

Internalization of Aeromonas hydrophila by fish epithelial cells can be inhibited with a tyrosine kinase inhibitor
by: Tan, E., et al.
Published: (2014)

Evaluation of Patients with Lung Cancer Treated with Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor
by: Laksmi Wulandari, et al.
Published: (2018)